SUZANNE CALHOUN: Open Payments
NPI 1508884693 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 27 payments from 12 companies in 2025. Trend: 2023 $264 · 2024 $572 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Alkermes, Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $42 |
| Lundbeck LLC | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: Auvelity, UZEDY, ABILIFY ASIMTUFII, ARISTADA, REXULTI, FANAPT, VRAYLAR, COBENFY.
Industry payments across LA — which companies pay providers there.
